Octopus Biosafety SA
EEURONEXT:MLOCT0.15
EUR
0.00
(0.00%)
ISIN
FR0013310281
Return %
Stock
S&P 500
1Y
-54.71
14.39
3Y
-36.36
81.42
5Y
-82.70
68.62
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Quarterly Revenue
EUR
•
in mil. unless spec.Quarterly Earnings Per Share
EUR
•
in mil. unless spec.Quarterly Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Bertrand Vergne
- Full Time Employees
- 6
- Sector
- Producer manufacturing
- Industry
- Industrial machinery
- Address
- 9 rue du Danemark Auray BR France 56400
- IPO Date
- Mar 14, 2018
- Website
- octopusbiosafety.com
- Similar Companies
- Business
- Octopus Biosafety S.A. designs, manufactures, and markets mobile, autonomous, intelligent, and modular robots primarily for the poultry farming industry and biosecurity applications. Its core products include the XO solution for continuous litter treatment and environmental and animal monitoring in poultry farms; the T-MOOV robot, which promotes bird movement and reduces floor egg counts; and the Easy-LIT electric scarifier designed to maintain poultry litter without noise, dust, or risk of injury. Additionally, the company develops autonomous decontamination robots targeting large-volume facilities such as warehouses, food factories, and airport terminals. Founded in 1987, Octopus Biosafety is headquartered in Auray, France, and operates both domestically and internationally. Recent major developments include a strategic alliance with The Autonomous Way Group Inc., formalized in June 2025, through which Octopus Biosafety integrated The Autonomous Way Group into its capital, acquiring a 20% stake in TAW Holding Inc. This partnership supports diversification into robotics and artificial intelligence applied to facility management and precision agriculture. Octopus Biosafety also announced a strategic partnership with EXCELCAR in November 2025 to advance industrial cleaning robotics. Additionally, in July 2025, the Lorient Commercial Court approved the company’s recovery plan aimed at financial and operational revitalization, with an expectation to achieve operational profitability from the second half of 2025. Octopus Biosafety serves agricultural, industrial, and biosecurity sectors with products that enhance productivity, animal welfare, hygiene, and disease control through automation and AI technologies. Its product portfolio focuses on special-purpose machinery contributing to improved operational efficiency in poultry farming and environmental decontamination. The company remains engaged in ongoing innovation of robotics solutions to address animal health, biosecurity challenges, and precision agriculture needs worldwide.